Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa

MONDAY, Oct. 7, 2024-- For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from...